Purpose: The purpose of this trial is to:
- Assess whether drug can hinder division, growth or lifespan of cancer cells
- Assess effectiveness of treatment on patients
- Monitor any side effects from use of treatment
Eligibility: To be eligible to join this clinical trial you must:
- Be at least 13 years old if you have osteosarcoma, or 18 years old in any other circumstances
- Have a measurable disease
- Not have had chemotherapy for at least six weeks
- Not have had radiation therapy to the brain for at least four weeks
- Not have had surgery for at least four weeks
Treatment: The process will entail:
- A five day continuous infusion of the drug every three weeks (up to nine courses)
- Evaluation at four weeks
Click Here To Return To The
Mesothelioma Clinical Trial Abstracts Overview Page.